Aileron Therapeutics Inc (NASDAQ:ALRN)
| 1.42 Delayed Data As of 3:55pm ET |  +0.02 / +1.43%Today’s Change | 1.25 Today|||52-Week Range 15.00 | -40.08% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 3.8M | 20.7M | 12.0M | 10.7M | |
| Short Term Investment Cash | -2.4M | 16.9M | -8.9M | -723.0K | ||
| Cash & Short Term Investments | 3.8M | 20.7M | 50.8M | 20.7M | ||
| Receivables | Receivables | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 258.0K | 333.0K | 1.0M | 1.1M | |
| Current Assets | 4.0M | 21.1M | 51.8M | 21.8M | ||
| Total Assets | Property, Plant and Equipment - Gross | 2.2M | 2.2M | 2.1M | 8.5M | |
| Depreciation | -1.9M | -2.1M | -2.0M | -1.2M | ||
| Other Assets | 1.5M | 778.0K | 694.0K | 679.0K | ||
| Total Assets | 5.9M | 22.0M | 52.7M | 30.3M | ||
| Liabilities | Accounts Payable | 641.0K | 2.0M | 1.6M | 1.7M | |
| Accrued Expenses | 1.1M | 1.2M | 2.2M | 2.2M | ||
| Other Current Liabilities | 1.1M | 1.2M | 2.2M | 2.2M | ||
| Other Liabilities | 2.5M | 4.1M | 4.9M | 5.4M | ||
| Total Liabilities | Long Term Debt | 0.00 | 0.00 | 0.00 | 5.3M | |
| Other Liabilities | 29.0K | 11.0K | 0.00 | 0.00 | ||
| Total Liabilities | 2.6M | 4.1M | 4.9M | 10.7M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 97.7M | 129.7M | 0.00 | 0.00 | ||
| Common Equity | -94.3M | -111.8M | 47.8M | 19.6M | ||
| Total Shareholder Equity | 3.4M | 17.9M | 47.8M | 19.6M | ||
| Share Information | Common Shares Outstanding | 14.7M | 14.7M | 14.7M | 14.7M | |
| Addtl. Info. | No data currently available for this section. | |||||
